Abstract
Tumor necrosis factor-α inhibitors are important adjunctive therapies for rheumatologic diseases. These agents increase the risk for granulomatous disease. We present a case of a woman with severe rheumatoid arthritis on infliximab who developed multiple nodular skin lesions. Biopsies grew Mycobacterium marinum. New lesions developed through therapy, necessitating surgical debulking.
| Original language | English |
|---|---|
| Pages (from-to) | 252-255 |
| Number of pages | 4 |
| Journal | Scandinavian Journal of Infectious Diseases |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2009 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver